How we write these guides
Who we are, where our facts come from, how we show prices, how we fix mistakes, and what we haven't done yet. The same rules apply to every country version.
We're an independent team. We take no drug-company money, run no ads for medicines and use no affiliate links. Every fact on a page comes from a source we opened and list at the bottom. Treat our pages as a guide to your questions, not as advice.
On this page
Who is behind GLP Guidebook?
A small, independent team that writes plain-language guides to GLP-1 medicines, with a separate version for each country we cover.
Each version follows its own country's regulator, prices and rules: India, the UK, Australia, Canada, the UAE and the US in English, France in French, Germany in German and Saudi Arabia in Arabic. Pick yours with the country button at the top of any page.
- No drug-company money. No maker, pharmacy or clinic pays us or sponsors a page.
- No ads for medicines. We don't run adverts for any medicine, brand or weight-loss clinic.
- No affiliate links. We earn nothing if you click a link or buy something.
- No brand picks. We name brands only to say what is approved and sold. We never rank them or say which one to buy.
Where do our facts come from?
We start with the most official source and only move down the list when it doesn't answer the question.
- Drug labels and regulators. The official prescribing information for each medicine, and notices from the country's own drug regulator and health ministry (for example CDSCO in India, the MHRA in the UK, the TGA in Australia, Health Canada, the FDA in the US, the ANSM in France, the BfArM in Germany and the SFDA in Saudi Arabia), plus the European Medicines Agency.
- Clinical guidelines. The country's own guidelines first (for example ICMR and the Endocrine Society of India, NICE in the UK, the HAS in France, the German S3 obesity guideline), then the World Health Organization (WHO).
- Published trials. Studies in medical journals, linked by their DOI or PubMed number, so you can find the original.
- Named news reports. Only for prices, launches, recalls and rules, always with the outlet's name and the date.
When two sources disagree, we say so and show both. When we can only find a press report, not the official notice behind it, we tell you that too.
When the authors of a guideline or expert statement declare payments from companies that make GLP-1 medicines, we note it next to that source, taken from the paper's own declaration of interests.
How do we show prices?
We show the official or list price only, and we say where each figure came from.
Each country version uses its own official price: for example the MRP (maximum retail price) in India, the official pharmacy price in France and Germany, and the SFDA-registered price in Saudi Arabia. Where there is no official price, we use the maker's published list price. In India we look for the MRP in this order:
- The maker's own announcement.
- A named news report, with its date.
- The government's price regulator (NPPA).
- Pharmacy listings, used only where at least two of them show the same MRP. We label these figures so you know.
We never show a seller's discounted price or a coupon price in our guides. Discounts change daily and differ by shop, and showing them would turn a guide into a shopping list. Your actual price may be lower than the price we show.
What does "no source, no sentence" mean?
If we can't point to a source we opened, the sentence doesn't go on the page.
Each factual sentence carries a small number. Tap it to jump to the source at the bottom of the page.
If a fact can't be checked, we cut it, or we say clearly that we couldn't confirm it. We give absolute numbers next to percentages, so a "50% lower risk" always comes with how many people that means.
Has a doctor checked these pages?
Not yet. Our pages are written from published sources, but no doctor has reviewed them.
That means a mistake could slip through, or a page could miss something that matters for you. Our sources are the safety net, which is why we list them all. When a doctor does review a page, we'll name them and the date on that page.
Use these guides to understand your options and plan your questions. Talk to a qualified doctor before starting, stopping or changing any medicine.
How do we keep pages up to date?
Every page shows when it was last updated, when its sources were last checked, and when its next review is due.
- Updated: the date at the top changes only when we make a real change, not for a typo.
- Last checked: the date we last opened the sources, shown above the disclaimer.
- Next review due: usually about 3 months later. Prices, launches and recalls change faster, so we re-check those whenever news breaks.
How do I report a mistake?
Use the form on our corrections page. There's a "Report an error" link at the end of every guide, blog post and answer.
We check every report against the original source and aim to fix confirmed errors within 7 days. Material corrections get a dated note on the page and an entry in our public log. Corrections: our policy, the report form and the log.
Is this medical advice?
No. It's general information to help you understand GLP-1 medicines and talk to a doctor.
We can't know your health history, your other medicines or your test results. Only a doctor who has seen you can decide whether a medicine suits you.
Where do I start?
With your own country's guides. Each version has 9 guides, plus tools, answers and a blog, written for that country.
